News RSS

For decades, GPs have primarily relied on standard lipid panels—especially LDL cholesterol—to gauge heart disease risk. However, a growing body of research indicates that apolipoprotein B100 (apoB100) can provide a more detailed and accurate view of cardiovascular health. By assessing the total number of atherogenic particles in circulation, apoB100 uncovers hidden risk that LDL cholesterol tests can miss.